Literature DB >> 14620134

Toll-like receptors and their signaling mechanisms.

Shizuo Akira1, Shintaro Sato.   

Abstract

Toll-like receptors (TLRs) play a crucial role in the recognition of invading pathogens and the activation of subsequent immune responses against them. Individual TLRs recognize distinct pathogen-associated molecular patterns (PAMPs). The TLR family harbors an extracellular leucine-rich repeat (LRR) domain as well as a cytoplasmic domain that is homologous to that of interleukin-1 receptor (IL-1R). Upon stimulation, TLR recruits IL-1R-associated protein kinases via adaptor MyD88, and finally induces activation of nuclear factor-kappaB and mitogen-activated protein kinases. However, the response to TLR ligands varies, indicating the diversity of TLR signaling pathways. Besides MyD88, several novel adaptor molecules have recently been identified. Differential utilization of these adaptor molecules may provide the specificity in the TLR signaling. Characterization of each TLR signaling pathway will reveal the molecular mechanism of self-tolerance as well as cross-tolerance in response to a variety of PAMPs.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14620134     DOI: 10.1080/00365540310015683

Source DB:  PubMed          Journal:  Scand J Infect Dis        ISSN: 0036-5548


  87 in total

1.  Activation of plasmacytoid dendritic cells by Kaposi's sarcoma-associated herpesvirus.

Authors:  John A West; Sean M Gregory; Vijay Sivaraman; Lishan Su; Blossom Damania
Journal:  J Virol       Date:  2010-10-27       Impact factor: 5.103

Review 2.  IL-17 family member cytokines: regulation and function in innate immunity.

Authors:  Joseph M Reynolds; Pornpimon Angkasekwinai; Chen Dong
Journal:  Cytokine Growth Factor Rev       Date:  2010-11-11       Impact factor: 7.638

3.  LPS-binding protein enables intestinal epithelial restitution despite LPS exposure.

Authors:  Juli M Richter; Brandon L Schanbacher; Hong Huang; Jianjing Xue; John A Bauer; Peter J Giannone
Journal:  J Pediatr Gastroenterol Nutr       Date:  2012-05       Impact factor: 2.839

Review 4.  Novel host response therapeutic approaches to treat periodontal diseases.

Authors:  Keith L Kirkwood; Joni A Cirelli; Jill E Rogers; William V Giannobile
Journal:  Periodontol 2000       Date:  2007       Impact factor: 7.589

5.  Early apoptosis of blood monocytes is a determinant of survival in experimental sepsis by multi-drug-resistant Pseudomonas aeruginosa.

Authors:  A Antonopoulou; M Raftogiannis; E J Giamarellos-Bourboulis; P Koutoukas; L Sabracos; M Mouktaroudi; T Adamis; Ira Tzepi; H Giamarellou; E E Douzinas
Journal:  Clin Exp Immunol       Date:  2007-05-04       Impact factor: 4.330

Review 6.  Disifin (sodium tosylchloramide) and Toll-like receptors (TLRs): evolving importance in health and diseases.

Authors:  Okom Nkili F C Ofodile
Journal:  J Ind Microbiol Biotechnol       Date:  2007-09-05       Impact factor: 3.346

7.  Endotoxin uptake in mouse liver is blocked by endotoxin pretreatment through a suppressor of cytokine signaling-1-dependent mechanism.

Authors:  Melanie J Scott; Shubing Liu; Richard A Shapiro; Yoram Vodovotz; Timothy R Billiar
Journal:  Hepatology       Date:  2009-05       Impact factor: 17.425

Review 8.  Modeling molecular and cellular aspects of human disease using the nematode Caenorhabditis elegans.

Authors:  Gary A Silverman; Cliff J Luke; Sangeeta R Bhatia; Olivia S Long; Anne C Vetica; David H Perlmutter; Stephen C Pak
Journal:  Pediatr Res       Date:  2009-01       Impact factor: 3.756

9.  Infant intestinal Enterococcus faecalis down-regulates inflammatory responses in human intestinal cell lines.

Authors:  Shugui Wang; Lydia Hui Mei Ng; Wai Ling Chow; Yuan Kun Lee
Journal:  World J Gastroenterol       Date:  2008-02-21       Impact factor: 5.742

10.  Toll-like receptor 4 Asp299Gly and Thr399Ile polymorphisms in gastric cancer of intestinal and diffuse histotypes.

Authors:  D Santini; S Angeletti; A Ruzzo; G Dicuonzo; S Galluzzo; B Vincenzi; A Calvieri; F Pizzagalli; N Graziano; E Ferraro; G Lorino; A Altomare; M Magnani; F Graziano; G Tonini
Journal:  Clin Exp Immunol       Date:  2008-09-29       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.